AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novem Group S.A.

Investor Presentation Dec 16, 2021

4509_ip_2021-12-16_fc0aa223-bc2a-42be-a66e-6e6f198c6943.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

16 December 2021

HY 2021/22 Results

  • Novem succeeded in acquiring a luxury SUV platform from Chinese premium customer Hongqi (FAW)
  • Sales representation opened in Japan to be able to deal with local customer base more effectively
  • Novem was able to take over a significant part of the aluminium interior trim business from Faurecia
  • Challenging trading conditions in Q2 2021/22 due to fluctuating production volumes of OEMs
  • Total revenue of €139.2m was down compared to the same reporting period last year by -18.3%
  • Adj. EBIT margin at 8.9% was adversely affected by higher input costs and inefficiencies
  • On a half-year basis, Adj. EBIT margin of 12.9% outperformed previous year by 4.0 percentage points
  • Solid net leverage of 1.6x as of 30 September 2021 following the completion of the refinancing

Unpredictable trading environment will last longer than expected

Q2 Sep 2020/21 Q2 Sep 2021/22
Revenue (€m) 170.4 139.2
Adj. EBIT (€m) 24.0 12.4
Adj. EBIT margin (%) 14.1% 8.9%
Free cash flow (€m) 45.2 0.9
Cash conversion (%) 88.9% 81.9%
Net leverage (x Adj. EBITDA) 2.8x 1.6x
HY Sep 2020/21 HY Sep 2021/22
Revenue (€m) 256.3 295.3
Adj. EBIT (€m) 22.9 38.2
Adj. EBIT margin (%) 8.9% 12.9%
Free cash flow (€m) 31.7 11.0
Cash conversion (%) 78.7% 89.4%
Net leverage (x Adj. EBITDA) 2.8x 1.6x

GROUP RESULTS

Revenue

  • In Q2 2021/22, overall revenue of €139.2m down by -18.3% in comparison to prior year (PY)
  • Revenue Series declined by -12.6% to €125.9m due to reduced production volumes of OEMs
  • While LMC market data suggested a reduction by -17.8% y/y for the relevant period, Novem could beat the general trend
  • In Q2 2021/22 several projects completed, however, PY turnover was inflated by catch-up effect in relation to Covid-19
  • If FX rates had remained constant at PY level, reported revenue would have been higher by +0.6%
  • In a twelve months view, Q2 2021/22 marked the weakest quarter affected by temporary production suspension of OEMs

  • Adj. EBIT in Q2 2021/22 decreased by €-11.6m which resulted in a margin of 8.9% for the period under review

  • Revenue as main driver for the reduced Adj. EBIT in Q2 2021/22 compared to last year
  • Volatile call-offs at short notice led to inefficiencies in managing personnel costs (unproductivity) and leased workers
  • Cost pressure from material price inflation of certain raw materials and purchased parts weighed high on the bottom line
  • Key commodities with the highest price hikes include aluminium, granulates, surface materials and adhesive films
  • In addition significantly increased freight expenses due to soaring transport costs, especially for overseas containers

Free cash flow

  • Free cash flow came down significantly by €-44.3m from last year and resulted in €0.9m in Q2 2021/22
  • Apart from the lower profit for the period, the decline was largely driven by the deliberate build-up of stock to ensure the deliveries to the OEMs and the massive rise of trade payable last year after the global lockdown
  • Unfavourable development of cash flow from operating activities (€-38.8m) due to the lower profit for the relevant period (€-8.9m), stock (€-12.6m), trade payables (€-11.5m) and Others (€-5.8m)
  • Higher cash out-flow for investing activities of €5.5m due to higher investments (€+6.2m), conversely higher cash received from disposals (€-0.4m), tooling interest (€-0.2m) and Others (€-0.2m)

Capital expenditure

  • Compared to last year, capital expenditure slightly increased in Q2 2021/22 by €+0.1m to €3.6m
  • In view of the lower revenue, the underlying capex ratio rose by +0.5pp to 2.6% (2.1% PY)
  • Given the challenging trading conditions, Novem tightly controlled investments which led to a LTM capex ratio of 2.1%
  • Additional investments expected in connection with the takeover of the Faurecia business in H2 2021/22 (c.€4.0m)
  • Apart from project related capex, Novem also took the opportunity to acquire equipment to cover future growth capex
  • It should be noted that, in this presentation, capital expenditure excludes any currency translation effects

Total working capital

LTM total working capital (€m)

  • As of 30 September 2021, total working capital stood at €139.3m which marked an increase of +8.2% y/y
  • Deviation of €-10.6m compared to PY resulted from higher tooling net (€-23.9m), higher inventories (€-14.3m) as well as higher trade payables (€+2.2m), conversely lower trade receivables (€+22.1m) and contract assets (€+3.3m)
  • As % of LTM revenue, total working capital stood at 21.7% as of 30 September 2021
  • Trade working capital (excluding tooling net and contract assets) showed a favourable decline of -19.2% from €52.1m to €42.0m
  • Measured in days outstanding, DSO of 28 (40 PY) and DPO of 54 (52 PY) developed satisfactorily
  • However, DIO ratio of 46 days (31 PY) deteriorated as a result of the deliberately higher safety stock levels across all regions

Capital structure

  • As of 30 September 2021, both gross financial debt and cash showed a significant decrease compared to 30 September 2020
  • On 26 July 2021 subsequent to the IPO, Novem fully repaid the €400.0m bond including accrued interest
  • As of 30 September 2021, the principal sources of funds were €71.4m cash (30 September 2020: €210.8m) and €51.5m derived from non-recourse factoring (30 September 2020: €43.3m)
  • Through the new financing structure, the net leverage ratio could be improved from 2.8x to 1.6x in the last twelve months
  • It should be noted that the definition of net leverage has changed in accordance with the new senior facilities agreement as of this reporting date and now includes lease liabilities

Revenue by operating segments

Europe Americas Asia

  • Revenue decreased in all regions (in total by -18.3% or €-31.2m), to the largest extent in Europe (€-20.5m y/y)
  • Amongst others, lower revenue particularly with Daimler platforms (E-class and C-class), partly offset by higher revenue of Daimler S-class and Volvo XC90 in Europe and GM Escalade in Americas
  • Decrease in Asia was impacted by catch-up effect in Q2 2020/21 when business picked up strongly after the global lockdown
  • LTM revenue could be allocated to the regions as follows: 51.7% Europe, 35.5% Americas and 12.8% Asia
  • LTM revenue received great momentum in Q4 2020/21 being the strongest quarter in the last twelve months

Adj. EBIT by operating segments

  • In line with the revenue trend, Adj. EBIT decreased in all regions with the biggest impact in Asia -57.8% y/y
  • As a consequence, Adj. EBIT margin decreased strongly, starting with Europe 5.8% (7.8% PY), followed by Americas 9.7% (16.9% PY) and Asia 19.8% (31.0% PY)
  • In Europe the Adj. EBIT of €3.9m (€6.9m PY) was mainly affected by the lower revenue, inefficiencies (in particular with the Daimler S-class in Vorbach), higher freight costs and a negative mix
  • In Americas the Adj. EBIT of €5.5m (€10.1m PY) was driven by increased material expenses, inefficiencies, higher freight costs and a negative FX impact
  • In Asia the Adj. EBIT of €2.9m (€7.0m PY) was mainly attributable to the reduced top line, lower governmental grants than previous year and higher social contributions
  • LTM Adj. EBIT hit by weak Q2 2021/22 and stands at €101.7m

Profit and loss statement (€m)

Q2
2020/21
Q2
2021/22
HY
2020/21
HY
2021/22
Revenue 170
4
139
2
256
3
295
3
Increase
or decrease
in
finished
goods
and
work
in
process
-15
6
3
2
-12
2
12
2
Total
operating
performance
154
8
142
4
244
1
307
5
Other
operating
income
2
6
6
8
3
2
9
5
Cost
of
materials
74
5
74
3
118
6
153
1
Personnel
expenses
36
0
39
1
65
6
79
1
Depreciation
, amortization
and
impairment
7
6
7
6
15
2
15
2
Other
operating
expenses
15
4
15
8
25
0
31
4
Adj
EBIT
24
0
12
4
22
9
38
2
Adjustments 0
2
2
5
0
3
3
1
Operating
result
(EBIT)
23
8
9
8
22
6
35
0
Finance
income
3
3
1
1
5
3
1
8
Finance
costs
13
0
11
7
25
6
22
2
Financial
result
-9
7
-10
6
-20
3
-20
4
Income
taxes
7
2
3
2
14
2
9
5
Deferred
taxes
0
4
-1
6
1
1
-0
6
Income
result
tax
7
6
1
6
15
2
8
9
Profit
for
the
period
6
5
-2
4
-12
9
5
8

Balance sheet

Balance sheet
(€m)
Sep
30
2020
Sep
30
2021
Sep
30
2020
Sep
30
2021
Total
equity
-532
2
19
9
Intangible
assets
3
3
3
4
Pensions
and
similiar
obligations
32
0
36
4
Property
, plant
and
equipment
190
3
179
9
Tax
liabilities
0
0
0
0
Trade
receivables
49
6
45
1
Other
provisions
8
1
5
1
Other
non-current
assets
14
4
14
4
Financial
liabilities
843
4
247
9
Deferred
tax
assets
15
3
8
5
Other
liabilities
33
4
31
6
Deferred
liabilities
tax
13
4
2
5
Total
non-current
assets
272
8
251
2
Total
liabilities
non-current
930
3
323
4
Inventories 90
1
113
0
Tax
liabilities
22
4
17
6
Trade
receivables
53
5
35
8
Other
provisions
44
8
46
9
Other
receivables
20
3
30
0
Financial
liabilities
77
6
1
4
Other
current
assets
18
7
13
9
Trade
payables
49
1
51
9
Cash
and
cash
equivalents
210
8
71
4
Other
liabilities
74
2
3
55
Asset
held
for
sale
0
0
1
2
Total
current
assets
393
5
265
2
Total
liabilities
current
268
1
173
1
Assets 666
3
516
4
Equity
and
liabilities
666
3
516
4

Cash flow statement

Cash flow statement (€m)

Q2
2020/21
Q2
2021/22
HY
2020/21
HY
2021/22
Profit
for
the
period
6
5
-2
4
-12
9
8
5
expense (+)/income
(-)
Income
tax
7
2
3
2
14
2
9
5
Financial
result
(+)/(-)
net
12
1
8
7
24
0
19
8
Depreciation
, amortization
and
impairment
7
6
7
7
15
2
15
3
Other
non-cash
expenses (+)/income
(-)
-14
2
-2
0
-24
5
-8
8
(-)/decrease
(+)
Increase
in
inventories
4
5
-8
1
4
5
-24
1
Increase
(-)/decrease
(+)
in
trade
receivables
9
-7
9
5
8
3
21
6
(-)/decrease
(+)
Increase
in
other
assets
3
7
-1
2
-3
6
-2
6
Increase
(-)/decrease
(+)
in
deferred
taxes
0
5
-1
7
1
3
-0
7
(-)/decrease
(+)
expenses/deferred
Increase
in
prepaid
income
0
3
2
3
-1
1
-1
1
(+)/decrease
(-)
Increase
in
provisions
10
4
-1
8
17
9
4
7
Increase
(+)/decrease
(-)
in
trade
payables
12
8
1
3
-8
8
-10
0
(+)/decrease
(-)
Increase
in
other
liabilities
3
3
-4
6
4
5
-4
3
Gain
(-)/loss
(+)
on disposals
of
non-current
assets
-0
0
-0
0
0
0
-0
0
Cash
(+)/cash
(-)
received
from
paid
for
for
income
taxes
-2
5
-4
4
-5
1
-6
7
Cash
flow
from
operating
activities
44
2
5
4
33
8
18
4

Cash flow statement (€m)

Q2
2020/21
Q2
2021/22
HY
2020/21
HY
2021/22
Cash
received
(+)
from
disposals
of
intangible
assets
0
1
0
1
Cash
(+)
from
of
received
disposals
, plant
and
equipment
property
-0
4
-0
1
-0
4
-0
1
Cash
paid
(-)
for
investments
in
intangible
assets
-0
3
-0
1
-0
3
-0
2
Cash
paid
(-)
for
investments
in
, plant
and
equipment
property
0
7
-5
5
-3
0
-8
9
Interest
received
(+)
0
9
1
1
1
5
1
8
Dividends
received
(+)
0
0
Cash
from/(used
flow
in)
investing
activities
0
9
-4
6
-2
2
4
-7
Cash
of
loans
repayments
-0
4
250
7
-2
2
250
7
Cash
received
from
loans
Cash
(-)
shareholders
of
the
repayments
to
parent
company
0
0
49
2
0
0
49
2
Cash
(-)
of
shareholders
loans
repayments
0
0
-0
0
0
0
0
0
Cash
from
(+)
of
received
issuance
bonds
0
3
-400
4
0
9
-400
0
Cash
paid
for
(-)
subsidies/grants
-0
0
-0
0
-0
0
-0
0
Cash
for
(-)
finance
paid
leases
-2
5
-1
6
-4
1
-4
0
Interest
paid
(-)
-6
0
2
-5
-11
6
-10
8
(-)
Dividends
paid
0
0
Cash
flow
from/(used
in)
financing
activities
-8
6
-107
2
-17
0
-114
8
Net
increase
(+)/
decrease
(-)
in
cash
and
cash
equivalents
36
5
-106
4
14
6
-103
9
Effect
of
exchange
fluctuations
on cash
and
cash
equivalents
rate
0
1
0
1
Cash
and
cash
equivalents
the
beginning
of
the
reporting
period
at
174
2
177
8
196
2
175
3
Cash
and
cash
equivalents
the
end
of
the
reporting
period
at
210
8
71
4
210
8
71
4

EBIT adjustments

EBIT adjustments (€m)

Q2
2020/21
Q2
2021/22
2020/21
HY
2021/22
HY
Revenue 170
4
139
2
256
3
295
3
EBIT 23
8
9
8
22
6
35
0
EBIT
margin
14
0%
1%
7
8
8%
11
9%
Restructuring
Exceptional
ramp-up costs
0
000000
0
000000
0
000000
0
000000
Material
quality
claims
-0
1
-0
1
Single
impairments
0
000000
0
000000
0
000000
0
000000
Covid-19
costs
0
0
0
1
0
0
0
4
Transaction
costs
2
2
2
4
Others 0
2
0
3
0
3
0
4
Exceptional
items
0
2
2
5
0
3
3
1
Discontinued
operations
Adjustments 0
2
2
5
0
3
3
1
Adj
EBIT
24
0
12
4
22
9
38
2
Adj
EBIT
margin
14
1%
8
9%
8
9%
12
9%
Depreciation
, amortization
and
impairment
7
6
7
6
15
2
15
2
Adj
EBITDA
31
5
20
0
38
1
53
4
Adj
EBITDA
margin
18
5%
14
4%
14
9%
18
1%

Definitions and basis of preparation of the financial information

  • Adj. EBIT is defined as EBIT as adjusted for certain adjustments which management considers to be non-recurring in nature, as Novem believes such items are not reflective of the ongoing performance of the business
  • Adj. EBITDA is defined as profit for the year before income tax result, financial result and amortization, depreciation and write-downs as adjusted for certain adjustments which management considers to be non-recurring in nature, as Novem believes such items are not reflective of the ongoing performance of the business
  • Adj. EBIT margin is defined as Adj. EBIT divided by revenue
  • Adj. EBITDA margin is defined as Adj. EBITDA divided by revenue
  • Capital expenditure is defined as the sum of cash paid for investments in property, plant and equipment and cash paid for investments in intangible assets excluding currency translation effects
  • Cash conversion rate is defined as Adj. EBITDA less capital expenditure divided by Adj. EBITDA
  • Days inventory outstanding (DIO) is defined by dividing inventories (as shown in the consolidated statement of financial position, but excluding tooling) by revenue generated from the sale of series trim elements in the last three months
  • Days sales outstanding (DSO) is defined by dividing trade payables (as shown in the consolidated statement of financial position, but excluding tooling) by revenue generated from the sale of series trim elements in the last three months
  • Days payables outstanding (DPO) is defined by dividing trade payables (as shown in the consolidated statement of financial position, but excluding tooling) by net costs series incurred in the three months
  • EBIT is defined as profit for the year before income tax result and financial result
  • EBITDA is defined as profit for the year before income tax result, financial result and amortization, depreciation and write-downs
  • Gross financial debt is defined as the sum of liabilities to banks, hedging and lease liabilities
  • Net leverage ratio is defined as the ratio of net financial debt to Adj. EBITDA
  • Net financial debt is defined as gross financial debt less cash and cash equivalents
  • Free cash flow is defined as the sum of cash flow from operating and investing activities
  • Trade working capital is defined as the sum of inventories non-tooling and trade receivables related to non-tooling less trade payables related to non-tooling
  • Total operating performance is defined as the sum of revenue and increase or decrease in finished goods
  • Total working capital is defined as the sum of inventories, trade receivables and contract assets excluding expected losses less trade payables, tooling received advance payments received and other provisions related to tooling
  • Net financial debt is defined as the sum of liabilities from bonds and liabilities to banks less cash and cash equivalents

Date of publication

16 December 2021

Contact

[email protected] | All information is constantly updated and available. Please visit the Investor Relations Portal on the Company website:https://ir.novem.com/websites/novem/English/1/investor-relations.html

Editor

Novem Group S.A. | 19, rue Edmond Reuter | 5326 Contern | Luxembourg | www.novem.com

Disclaimer

Novem Group S.A. (the "Company", "Novem") has prepared this presentation solely for your information. It should not be treated as giving investment advice. Neither the Company, nor any of its directors, officers, employees, direct or indirect shareholders and advisors nor any other person shall have any liability whatsoever for any direct or indirect losses arising from any use of this presentation. While the Company has taken all reasonable care to ensure that the facts stated in this presentation are accurate and that the opinions contained in it are fair and reasonable, this presentation is selective in nature. Any opinions expressed in this presentation are subject to change without notice and neither the Company nor any other person is under any obligation to update or keep current the information contained in this presentation. Where this presentation quotes any information or statistics from any external source, you should not interpret that the Company has adopted or endorsed such information or statistics as being accurate. This presentation contains forward-looking statements, which involve risks, uncertainties and assumptions that could cause actual results, performance or events to differ materially from those described in, or expressed or implied by, such statements. These statements reflect the Company's current knowledge and its expectations and projections about future events and may be identified by the context of such statements or words such as "anticipate", "believe", "estimate", "expect", "intend", "plan", "project" and "target". No obligation is assumed to update any such statement. Numbers were rounded to one decimal. Due to rounding, the numbers presented may not add up precisely to the totals provided.

Novem Group S.A. 19, rue Edmond Reuter | 5326 Contern | Luxembourg

E-Mail: [email protected] www.novem.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.